Drug Profile
Research programme: cancer vaccine CD55 - Scancell
Latest Information Update: 30 May 2007
Price :
$50
*
At a glance
- Originator Scancell
- Developer Cancer Research Technology; Scancell
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 21 Jun 2004 Preclinical trials in Solid tumours in United Kingdom (unspecified route)